Bos Sci's new BMS nets EU approval

Justine Varieur Cadet | | Health Imaging | Screening
Boston Scientific has received the CE mark for its Omega platinum chromium bare-metal stent (BMS) system, its third-generation coronary stenting technology.

The Natick, Mass.-based company said the stent incorporates its platinum chromium (PtCr) alloy designed for coronary stenting and is intended to provide interventional cardiologists with a BMS to treat patients with coronary artery disease. The Omega stent system is part of Boston Scientific's PtCr stent series, which includes the Taxus Element paclitaxel-eluting stent system and the Promus Element everolimus-eluting stent system.

Boston Scientific said it will immediately begin marketing the Omega stent system in the European Union and other CE mark countries.

Justine Varieur Cadet

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.